pristinamycin IIA   Click here for help

GtoPdb Ligand ID: 12933

Synonyms: mikamycin A | ostreogrycin A | Pyostacine® | streptogramin A | virginiamycin M1
Approved drug PDB Ligand
pristinamycin IIA is an approved drug (France, 1995)
Comment: Pristinamycin IIA is a macrolide that is, together with pristinamycin IA, a component of pristinamycin (PubChem CID 11979535), a streptogramin antibacterial produced by Streptomyces pristinaespiralis [1]. Note that the INN describes the mixture.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 10
Hydrogen bond donors 2
Rotatable bonds 1
Topological polar surface area 134.6
Molecular weight 525.59
XLogP 1.38
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C)[C@@H]1[C@H](C)/C=C/C(=O)NC/C=C/C(=C/[C@H](CC(=O)CC2=NC(=CO2)C(=O)N3CCC=C3C(=O)O1)O)/C
Isomeric SMILES C[C@@H]1/C=C/C(=O)NC/C=C/C(=C/[C@H](CC(=O)CC2=NC(=CO2)C(=O)N3CCC=C3C(=O)O[C@@H]1C(C)C)O)/C
InChI InChI=1S/C28H35N3O7/c1-17(2)26-19(4)9-10-24(34)29-11-5-7-18(3)13-20(32)14-21(33)15-25-30-22(16-37-25)27(35)31-12-6-8-23(31)28(36)38-26/h5,7-10,13,16-17,19-20,26,32H,6,11-12,14-15H2,1-4H3,(H,29,34)/b7-5+,10-9+,18-13+/t19-,20-,26-/m1/s1
InChI Key DAIKHDNSXMZDCU-FQTGFAPKSA-N
No information available.
Summary of Clinical Use Click here for help
Pristinamycin has been authourised by the French national medicine agency (ANSM) since 1995 and marketed under the trade name Pyostacine®. It is indicated as an oral treatment for bacterial infections of the respiratory system and of skin and soft tissues. We have been unable to find information regarding current approval of this drug in other jurisdictions.